This study found that AKAP5 as a protective factor in GC patients showed higher expression level in patients with low IAS, but Zhong et al. (2020) pointed out that AKAP5 is a protective factor when it is low-expressed. The gene discussed is AKAP5; the disease is gastric cancer.